NEW YORK, July 28, 2014 /PRNewswire/ -- David Hardison, Ph.D., vice president of health services for ConvergeHEALTH by Deloitte, has been elected chairman of the board for the Clinical Data Interchange Standards Consortium, a non-profit working to establish common protocols around the use of clinical research data, particularly as it relates to electronic health records.
Hardison will work to continue CDISC's mission of collaborating with organizations across the research and health care arena in harmonizing practices related to the acquisition, exchange, submission and archiving of clinical data and metadata. He previously served as CDISC's chairman from 2005 to 2007.
"We are pleased to have David chair the organization once again and bring his expertise in the field to our organization," said Dr. Rebecca Kush, president and chief executive officer of CDISC. "CDISC appreciates that ConvergeHEALTH supports the open-source development of data standards and innovation to improve medical research and interoperability in many areas of health care."
Hardison said his appointment reflects Deloitte's commitment to the importance of standards-based innovation in health care. "I have been a champion of CDISC for many years and look forward to my continued support of the organization and its vision to 'inform patient care and safety through higher quality medical research.'"
Hardison has more than 30 years of experience in the biopharmaceutical and providers sectors, including executive and board-level roles related to information technology and performance improvement.
Hardison will speak at the CDISC Asia-Pacific/Japan Interchange 2014 on July 31 in Tokyo, an event that runs from July 28 through Aug. 1.
CDISC is a 501(c)(3) global non-profit charitable organization with more than 300 supporting member organizations from across the clinical research and health care arenas. Through the efforts of volunteers around the globe, CDISC catalyzes productive collaboration to develop industry-wide data standards enabling the harmonization of clinical data and streamlining research processes from protocol through analysis and reporting, including the use of electronic health records to facilitate the collection of high quality research data. The CDISC standards and innovations can significantly decrease the time and cost of medical research and improve quality, thus contributing to the faster development of safer and more effective medical products and a learning health care system. The CDISC vision is to inform patient care and safety through higher quality medical research. For more information, visit http://www.cdisc.org/.
About ConvergeHEALTH by Deloitte
ConvergeHEALTH brings powerful, demonstrated analytics platforms and data models from Recombinant by Deloitte, advanced proprietary and open-source analytics, content and benchmarks through collaboration with industry leaders and deep experiences from Deloitte's Life Sciences and Health Care consulting practice to help our clients survive and thrive in the new paradigm of value-based, personalized medicine. For more information, visit www.converge-health.com.
As used in this document, "Deloitte" means Deloitte Consulting LLP, a subsidiary of Deloitte LLP. Please see www.deloitte.com/us/about for a detailed description of the legal structure of Deloitte LLP and its subsidiaries. Certain services may not be available to attest clients under the rules and regulations of public accounting.